Introduction
Hawthorn, a common name of all plant species in the genus Crataegus, is a thorny shrub or small tree [1] . Hawthorn is a member of the Rosaceae family and is recognized to have approximately 280 species primarily from northern temperate zones in East Asia, Europe, and eastern North America [2, 3] . Crataegus sinaica (C. sinaica) grows wildly in the mountains area in Saint Catherine Protectorate, South Sinai, Egypt, and known as Za'rur or Za'rur al-awdiyah [4] . Flavonoids and procyanidins are considered as the most important constituents and primarily responsible for the pharmacological activity of hawthorn [5] . The fruits contain relatively low levels of flavonoids and consist primarily of oligomeric and polymeric procyanidins [6] . Data regarding the young stems and seeds are lacking. Among cardioactive medicinal plants that do not contain typical cardiac glycosides, hawthorn (Crataegus) has taken a special position since centuries [7] . Crataegus species are famous in folk medicine and are widely used in phytotherapy due to their improvement of the heart function in declining cardiac performance equivalent to stages I and II of the NYHA classification [8] [9] [10] . It was deemed important to evaluate the phytoconstituents and bioactivities of C. sinaica growing in Egypt. The antiviral and antioxidant activity of some fractions and of a series of flavonoids and proanthocyanidins obtained from C. sinaica was valuated [11] . The O-glycosidic flavonoids and oligomeric proanthocyanidins exhibited significant inhibitory activity against herpes simplex virus type 1 (HSV-1), which was shown to be due to an extracellular mechanism for procyanidin C1 [12] . However, studies evaluating cardiac activity and hepatoprotection of C. sinaica have not done yet.
Materials and methods

General experiment
Objective: To evaluate the cardiac activity and hepatoprotection of Crataegus sinaica (C. sinaica). Methods: All the isolated compounds were isolated by open-column liquid chromatography (CC) using sephadex LH-20 as stationary phase. Elution of the column was performed with EtOH or MeOH. The phytochemical investigation of the young stem of C. sinaica for the first time together with the leaves and flowers lead to the isolation and identification of quercetin, hyperoside, vitexin-2''-O-rhamnoside, epicatechin, procyanidin B2 and procyanidins C1. Results: Rats treated with the low and high dose of C. sinaica leaves with flowers extract showed 15% and 17% reduction in the heart rate, and reduction in the STsegment by 107% and 57%; respectively. The T-amplitude was decreased by 59% of the high dose extract. On the other hand, the young stems and leaves with flowers extracts of C. sinaica on primary culture of rat hepatocytes monolayer indicated a hepatoprotection for the total extract, ethyl acetate, butanol, and chloroform fractions at 100 毺 g/mL, 75 毺 g/mL, 50 毺 g/mL, and 25 毺 g/mL; respectively. Conclusions: The results of these chemical and biological studies suggest the use of C. sinaica growing in Egypt as a preventive drug against cardiovascular and hepatic diseases. The chemical studies suggest the use of woody young stems as a newly investigated bioactive organ. The extraction of unsaturated fatty acids from the seeds of the plant would serve as a good health and nutritive product.
TLC was carried out on precoated 0.2 mm layer silica gel F 254 plates (Merck) developed with ethyl acetate -formic acid -acetic acid-water (30:1.2:0.8:8 v/v). Spots were detected using naturstoff (NA) reagent (2-aminoethyl diphenylborate) 1% w/v in absolute methanol for flavonoids [13] , reagent (ii) (vanillin 1% in MeOH and 5% H 2 SO 4 in EtOH) for proanthocyanidins analysis [12] , UV at 254 and 366 nm for UV detection. UV spectra were measured as diluted samples in MeOH on a Uvikon 931 double beam UV-VIS spectrophotometer in the region of 200-500 nm. FAB-MS spectral analyses in negative or positive mode were performed on a VG 70-SEQ hybrid mass spectrometer. EIMS were recorded on the same instrument by means of a direct insertion probe at ionization energy of 70 ev. 
High performance liquid chromatography analysis
High performance liquid chromatography(HPLC) analysis was carried out using Agilent 1 200 equipment with quaternary pump, auto sampler injector. The chromatograms were detected with a DAD (80 Hz) for full spectral acquisition. The automated Quaternary LC system was operated and data was managed using HewlettPackard model computer. Zobrax Eclipse XDB-C18 Column (Analytical 4.6 伊150 mm; 5 microns) was used at temperature 25 曟 .
Plant materials
C. sinaica were obtained from Wadi Gebal in Saint Catherine Protectorate (South Sinai, Egypt) in November 2005. Voucher specimens were kindly identified by Prof. Dr. K. H. El-Batanouny, Botany Department, Faculty of Science, Cairo University, Egypt. It was air-dried, then segregated into leaves with flowers, young stems, and fruits; from which seeds were further separated.
Authentic reference compounds
Quercetin were previously isolated and purified from the leaves of C. sinaica [11] . Vitexin-2''-O-rhamnoside & hyperoside were purchased from ROTH. Epicatechin was purchased from Sigma Chemical Co. (St. Louis, MO). B2 and C1 were previously isolated and purified from the leaves of C. sinaica [12] .
Extraction and isolation
The air-dried and powdered leaves with flowers and young stems (1 500 g), and fresh fruits (2 000 gm) were extracted exhaustively with 70% and 80% aqueous acetone; respectively at room temperature. The combined filtrates were concentrated in vacuo at 40 曟 then subjected to lyophilization. Then extracted successively with CHCl3 (300 mL 伊 3), EtOAc (500 mL 伊 5), and BuOH (150 mL 伊 3); respectively. Each fraction was completely dried in vacuo at 40 曟and the final dry weight was noted.
2.6.Sample preparation for HPLC
Two g of dried powder were extracted 3 times with 200 mL 70% acetone. The extract was reduced to about 10 mL in vacuo and then diluted with 20 mL of distilled water and defatted with petroleum ether. The aqueous layer was evaporated to dryness, then dissolved in methanol and transferred to a 25 mL measuring flask and continued to the mark with methanol (solution A). 5 mL of solution A were filtered through a 25 mm filter, pp 0.45 Nylon and diluted to 10 mL with methanol. A 20 毺L of this solution was injected.
Solvent system
Isocratic elution of A: Water/Formic acid (0.05%) (86%) and B: Acetonitrile (14%). Standard authentics concentration: 1 mg/mL (0.8 mL/min flow rate).
Biological activities analysis
In vivo bioassay using cardiac activity was performed according to the method of Vish Nevskeya [14] . For this purpose 36 rats weighing 250-300 g were used (from the animal house colony of the NRC) and Epinephrine (Epinephrine®) was purchase from Misr for pharmaceutical products, Egypt. It has been established that within 5 minutes of intramuscular injection of 0.8 mL epinephrine in white rats myocardial ischemia appeared. ECG changes appeared in the form of depressed ST-segment, heart rate changes and diminution or inversion of the T-amplitude.
Rats were divided into 5 groups as follow: The 1st group served as control and received distilled water, the 2nd and 3rd group received low dose level (10 mg/kg/day) and high dose level (100 mg/kg/day) of C. sinaica leaves with flowers extract; respectively, the 4th and 5th group received low dose level (10 mg/kg/day) and high dose level (100 mg/kg/ day) of the leaves with flowers extract standard (Crataegi Foui Cum Flore Extract; Siccum, Certa, from Belgium); respectively. The ECG changes were measured using ECG in standard lead II using power lab ECG module.
Hepatoprotection and cytotoxicity using MTT colorimetric assay
Primary culture of rat hepatocytes was prepared according to method [15] , modified by Kiso [16] , using Westar male rats (250-300 g), obtained from the animal house of the NRC. Culture medium composed of RPMI-1640 medium(100 mL), supplemented with 10% inactivated (56 曟 for 30 min) fetal calf serum (FBS), penicillin-streptomycin (PS) (0.01 g/mL), insulin (0.7 g/mL) and dexamethasone (4 g/mL). All items were purchased from Sigma-aldrich Company. Inocula of 4伊10 6 cells/mL were seeded into sterile plastic 96-well plates and incubated in CO 2 -Incubator at 37 曟, under 5% CO 2 in air for 22-24 hrs. All buffers were freshly prepared and sterilized at 121 曟 for 30 min. before use. Four extract and fractions (total acetonic extract and EtOAc, BuOH and CHCl 3 fractions) from both the leaves with flowers and young stems extracts of C. sinaica were tested for their potential cytotoxic and hepatoprotective activity.
Evaluation of hepatoprotective activity undergo by preparing different concentrations from each of the extracts of C. sinaica, starting from 25 毺 g/mL and increasing concentrations in ascending order by dissolving in DMSO (1% maximum concentration). For each concentration, three replicates were carried out, in addition to controls which were: cell control (i.e., cells only), 50% of cell control, negative control: 20 mM paracetamol (i.e., cells + paracetamol), positive control: 50 毺 g/mL Sylimarin (i.e., cells + sylimarin + paracetamol).
In order to determine LC 50 , different concentrations were prepared for each of the extracts. The range of concentrations used started from 100 毺 g/mL followed by increasing concentrations in ascending order up to the concentration 1 000 毺 g/mL to determine the concentration that induce death for half the number of cells. C. sinaica extracts were dissolved in dimethylsulphoxide (DMSO) (1% maximum concentration). For each concentration, three replicates were carried out, in addition to controls which were: Cell control (i.e., cells only), 50% of cell control Evaluation of the effect of the different extracts on cultured hepatocytes was obtained by calculating the absorption of the cell viability with respect to control cells (cells only without addition of C. sinaica extracts). Each experiment was carried out twice to confirm validity of results. A graph was plotted with x-axis showing different concentrations of extracts used, y-axis showing absorbance percentage of viable cells.
Results
Bioactivites
Cardiovascular activity
All groups showed no significant effect for the ECG changes after one week administration of the drug. In the positive control group heart rate was reduced by 27% and the ST-segment was reduced by 247%.
Rats treated by the low and high dose of C. sinaica leaves with flowers extract showed 15% and 17% reduction in the heart rate, and reduction in the ST-segment by 107% and 57% respectively. The T-amplitude was decreased by 59% of the high dose extract. On the other hand, the rats treated by the low and high dose of the leaves with flowers extract standard (Crataegi Foui Cum Flore Extract) showed 27% and 22% reduction in the heart rate and reduction in the ST-segment by 111% and 42%; respectively. The T-amplitude was decreased by 41% of the high dose standard (Table 1, Figure 1 & 2) . Both the standard drug and the tested extracts showed a protective effect on the heart especially in the high dose level. These results prove the efficacy of Crataegus growing in Egypt and possibility of using it therapeutically in cardiovascular diseases.
Hepatoprotection and cytotoxicity
Data were subjected to analysis of variance and treatment means were compared by an approximate Student's t-test (P<0.05). All treatments in experiments described consisted of three replicates.
The results of leaves with flowers, as well as, young stems extracts of C. sinaica indicated that they exhibited hepatoprotection for total extract, ethyl acetate, butanol, and chloroform fractions at 100 毺 g/mL, 75 毺 g/mL, 50 毺 g/mL, and 25 毺 g/mL; respectively ( Figure 3 & 4, Table 2 & 3) .
The viability assay was applied with a broad range of concentrations of the studied extracts (from 100-1000 mg/mL) on monolayer of rat hepatocytes. It revealed that with the given extracts, increasing absorbance values were observed with increasing concentrations from 100 毺 g/mL to 1 000 毺 g/mL in monolayer culture of primary rat hepatocytes except in the CHCl 3 , however no cytotoxicity was observed microscopically in the cellular systems, as shown in Table 4 
Discussion
The need for drugs originating from plant materials, and directed for preventing serious diseases as cardiovascular and hepatic diseases is a national need. In this study, the identification of C. sinaica compounds was elucidated by means of TLC, FAB-MS, NMR spectroscopy and cochromatography with HPLC. The cardiovascular and hepatoprotective activities of different fractions obtained from C. sinaica leaves with flower and the young stems extracts were investigated.
The main active constituents such as hyperoside, vitexine-2"-O-rhamnoside, epicatechin, procyanidin B2 and procyanidin C1 were isolated and identified from the young stems and confirmed by comparison with previously reported data [11, 17] . The presence of those main active constituents explains the biological results discussing the similarity of bioactivities of both C. sinaica and other species used abroad in phytopharmaceuticals. These new findings allow the use of young stems beside the leaves of C. sinaica biologically.
The increase of absorbance values in some samples was not false negative result for cytotoxicity, as microscopic examination confirmed the viability of the cultured hepatocytes.
The revealed data showed no cytotoxicity exerted by the leaves or young stems of C. sinaica in the given range, but leaves had greater safety margin. Also, the chloroformic extract in both parts had a decreasing safety margin with increased concentration. For the hepatoprotection, almost complete hepatoprotection occurred for all fractions of leaves and young stems taking in consideration that the chloroformic extracts always showed prominent at low doses and protection decreased with increased concentration. These new findings may have great impact for future use of C. sinaica for the first time in hepatic disorders.
In conclusion, the results of these chemical and biological studies suggest the use of C. sinaica growing in Egypt as a preventive drug against cardiovascular and hepatic diseases. The chemical studies suggest the use of woody young stems as a newly investigated bioactive organ. The extraction of unsaturated fatty acids from the seeds of the plant would serve as a good health and nutritive product.
